Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01614587 · ClinicalTrials.gov registry record
Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?
A clinical trial, sponsored by Atlantic Health System.
- Completed
- Registry status
- 50
- Enrollment target
NCT01614587 is a clinical trial that has completed, run by Atlantic Health System. The registered enrollment target is 50 participants.
The verdict
NCT01614587 has completed, sponsored by Atlantic Health System.
- COMPLETED
- Registry status
- 50 participants
- Enrollment target
Study Summary
The objective is to explore the genetic predisposition to early pelvic organ prolapse after adequate surgical repair by exploring the association between pelvic organ prolapse recurrences and certain polymorphisms.
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2012-03 |
| Est. Completion | 2015-04 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01614587
The ClinicalTrials.gov registry entry for NCT01614587 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 50 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Atlantic Health System, which has 43 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01614587 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01614587 about?
NCT01614587 is a clinical study titled "Do Patients With Early Post Operative Recurrence of Pelvic Organ Prolapse Have a Genetic Predisposition?". The objective is to explore the genetic predisposition to early pelvic organ prolapse after adequate surgical repair by exploring the association between pelvic organ prolapse recurrences and certain polymorphisms.
What is the current status of trial NCT01614587?
This trial is currently completed. The enrollment target is 50 participants. The study started on 2012-03. Estimated completion is 2015-04.
Who is sponsoring clinical trial NCT01614587?
This trial is sponsored by Atlantic Health System, which has 43 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.